Steinar Madsen

1.1k total citations
44 papers, 833 citations indexed

About

Steinar Madsen is a scholar working on Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Cell Biology. According to data from OpenAlex, Steinar Madsen has authored 44 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pediatrics, Perinatology and Child Health and 7 papers in Cell Biology. Recurrent topics in Steinar Madsen's work include Aldose Reductase and Taurine (6 papers), Pharmaceutical studies and practices (5 papers) and Biochemical effects in animals (4 papers). Steinar Madsen is often cited by papers focused on Aldose Reductase and Taurine (6 papers), Pharmaceutical studies and practices (5 papers) and Biochemical effects in animals (4 papers). Steinar Madsen collaborates with scholars based in Norway, United Kingdom and United States. Steinar Madsen's co-authors include Jon Storm‐Mathisen, Ole Petter Ottersen, Ole P. Ottersen, Ingebjørg Buajordet, Inger Cappelen, Berit Feiring, Hanne Nøkleby, Anders Engeland, Håkon K. Gjessing and Nina Gunnes and has published in prestigious journals such as New England Journal of Medicine, The American Journal of Cardiology and Experimental Brain Research.

In The Last Decade

Steinar Madsen

38 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steinar Madsen Norway 13 237 214 161 140 127 44 833
Hideki Onishi Japan 22 300 1.3× 112 0.5× 136 0.8× 66 0.5× 451 3.6× 165 1.8k
Bernard Jeune Denmark 15 217 0.9× 31 0.1× 307 1.9× 22 0.2× 204 1.6× 24 1.1k
M. Földi Hungary 15 96 0.4× 251 1.2× 112 0.7× 30 0.2× 117 0.9× 90 1.1k
Jenny Tse United States 20 183 0.8× 50 0.2× 167 1.0× 30 0.2× 314 2.5× 51 1.1k
Shuang Bai China 18 266 1.1× 71 0.3× 61 0.4× 20 0.1× 214 1.7× 61 1.1k
A. M. Cohen Israel 21 154 0.6× 15 0.1× 329 2.0× 86 0.6× 214 1.7× 61 1.2k
Bridget Martell United States 12 244 1.0× 284 1.3× 180 1.1× 19 0.1× 444 3.5× 17 1.7k
Shin Hye Yoo South Korea 17 57 0.2× 147 0.7× 46 0.3× 159 1.1× 286 2.3× 70 994
Jianhua Liu China 16 468 2.0× 34 0.2× 206 1.3× 33 0.2× 128 1.0× 38 1.2k
Upinder Kaur India 20 184 0.8× 79 0.4× 186 1.2× 10 0.1× 174 1.4× 92 1.2k

Countries citing papers authored by Steinar Madsen

Since Specialization
Citations

This map shows the geographic impact of Steinar Madsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steinar Madsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steinar Madsen more than expected).

Fields of papers citing papers by Steinar Madsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steinar Madsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steinar Madsen. The network helps show where Steinar Madsen may publish in the future.

Co-authorship network of co-authors of Steinar Madsen

This figure shows the co-authorship network connecting the top 25 collaborators of Steinar Madsen. A scholar is included among the top collaborators of Steinar Madsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steinar Madsen. Steinar Madsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garcia, Beate Hennie, et al.. (2017). Safety and efficiency of a new generic package labelling: a before and after study in a simulated setting. BMJ Quality & Safety. 26(10). 817–823. 8 indexed citations
2.
Gjersvik, Petter & Steinar Madsen. (2015). Biotilsvarende legemidler. Tidsskrift for Den norske legeforening. 135(10). 962–962.
3.
Håberg, Siri E., Lill Trogstad, Nina Gunnes, et al.. (2013). Risk of Fetal Death After Pandemic Influenza Virus Infection or Vaccination. Obstetrical & Gynecological Survey. 68(5). 348–349. 9 indexed citations
4.
Håberg, Siri E., Lill Trogstad, Nina Gunnes, et al.. (2013). Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination. New England Journal of Medicine. 368(4). 333–340. 218 indexed citations
5.
Madsen, Steinar, et al.. (2012). Legemiddelmangel - årsaker og tiltak. Tidsskrift for Den norske legeforening. 132(19). 2154–2155. 2 indexed citations
6.
Fretheim, Atle, Jan Odgaard‐Jensen, Odd Brørs, et al.. (2012). Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis. BMC Medicine. 10(1). 33–33. 61 indexed citations
7.
Blystad, H, Gabriel Ånestad, Didrik F. Vestrheim, Steinar Madsen, & Karin Rønning. (2012). Increased incidence of Mycoplasma pneumoniae infection in Norway 2011. Eurosurveillance. 17(5). 40 indexed citations
8.
Madsen, Steinar & Edel Holene. (2007). Lavere digitalisdosering ved hjertesvikt. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
9.
Reikvam, Åsmund, Sofie Hexeberg, Tore K Kvien, et al.. (2006). [Clinical use of COX inhibitors--a consensus].. PubMed. 126(5). 591–5. 5 indexed citations
10.
Reikvam, Åsmund, Sofie Hexeberg, Tore K Kvien, et al.. (2006). Klinisk bruk av COX-hemmere – en konsensus. Tidsskrift for Den Norske Laegeforening. 2 indexed citations
11.
Gullestad, Lars & Steinar Madsen. (2004). Moderne diagnostikk og behandling av kronisk hjertesvikt. Tidsskrift for Den Norske Laegeforening. 2 indexed citations
12.
Fjeld, Bente, et al.. (2004). [Clinical trials in Norway--completion and reporting are not satisfactory].. PubMed. 124(22). 2888–90. 2 indexed citations
13.
Gullestad, Lars & Steinar Madsen. (2004). [Modern diagnosis and treatment of heart failure].. PubMed. 124(8). 1107–10. 1 indexed citations
14.
Buajordet, Ingebjørg, et al.. (2003). Bivirkningsrapportering og legemiddelovervåking. Tidsskrift for Den Norske Laegeforening. 2 indexed citations
15.
Reikvam, Åsmund, et al.. (2003). Warfarinbehandling og blødninger. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
16.
Geiran, Odd, et al.. (2003). Pulmonal arteriell hypertensjon behandlet med prostasyklin eller kalsiumblokade. Tidsskrift for Den Norske Laegeforening.
17.
Gullestad, Lars, Svein Simonsen, Thor Ueland, et al.. (1999). Possible role of proinflammatory cytokines in heart allograft coronary artery disease. The American Journal of Cardiology. 84(9). 999–1003. 44 indexed citations
18.
Madsen, Steinar, et al.. (1990). Immunocytochemical localization of taurine: methodological aspects.. PubMed. 351. 37–44. 13 indexed citations
20.
Madsen, Steinar, Ole Petter Ottersen, & Jon Storm‐Mathisen. (1987). Immunocytochemical Demonstration of Taurine. Advances in experimental medicine and biology. 217. 275–284. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026